Page last updated: 2024-08-21

nsc 65346 and Carcinoma, Ehrlich Tumor

nsc 65346 has been researched along with Carcinoma, Ehrlich Tumor in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Glazer, RI; Saffer, JD1
Cohen, OJ; Glazer, RI; Hartman, KD1

Other Studies

2 other study(ies) available for nsc 65346 and Carcinoma, Ehrlich Tumor

ArticleYear
Inhibition of histone H1 phosphorylation by sangivamycin and other pyrrolopyrimidine analogues.
    Molecular pharmacology, 1981, Volume: 20, Issue:1

    Topics: Animals; Carcinoma, Ehrlich Tumor; Cell Nucleus; Histones; In Vitro Techniques; Mice; Phosphorylation; Protein Kinase Inhibitors; Pyrimidine Nucleosides; RNA, Neoplasm; Toyocamycin

1981
Effect of sangivamycin and xylosyladenine on the synthesis and methylation of polysomal ribonucleic acid in Ehrlich ascites cells in vitro.
    Biochemical pharmacology, 1981, Oct-01, Volume: 30, Issue:19

    Topics: Adenosine; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Cells, Cultured; Methylation; Mice; Pyrimidine Nucleosides; RNA, Neoplasm

1981